nodes	percent_of_prediction	percent_of_DWPC	metapath
L-Arginine—NOS2—Dexamethasone—hematologic cancer	0.161	0.376	CbGbCtD
L-Arginine—NOS3—Doxorubicin—hematologic cancer	0.134	0.312	CbGbCtD
L-Arginine—NOS2—Doxorubicin—hematologic cancer	0.134	0.312	CbGbCtD
L-Arginine—SLC7A3—lung—hematologic cancer	0.00555	0.0527	CbGeAlD
L-Arginine—SLC7A3—testis—hematologic cancer	0.00524	0.0497	CbGeAlD
L-Arginine—AZIN2—lung—hematologic cancer	0.00495	0.047	CbGeAlD
L-Arginine—SLC7A4—testis—hematologic cancer	0.00487	0.0462	CbGeAlD
L-Arginine—AZIN2—testis—hematologic cancer	0.00467	0.0443	CbGeAlD
L-Arginine—ASL—lung—hematologic cancer	0.0046	0.0436	CbGeAlD
L-Arginine—ARG2—hematopoietic system—hematologic cancer	0.00444	0.0421	CbGeAlD
L-Arginine—ASL—testis—hematologic cancer	0.00434	0.0412	CbGeAlD
L-Arginine—SLC7A1—gonad—hematologic cancer	0.00395	0.0375	CbGeAlD
L-Arginine—AZIN2—lymph node—hematologic cancer	0.00338	0.0321	CbGeAlD
L-Arginine—ARG2—gonad—hematologic cancer	0.00337	0.032	CbGeAlD
L-Arginine—ASL—lymph node—hematologic cancer	0.00314	0.0299	CbGeAlD
L-Arginine—NOS3—hematopoietic system—hematologic cancer	0.0031	0.0294	CbGeAlD
L-Arginine—SLC7A1—lung—hematologic cancer	0.00301	0.0286	CbGeAlD
L-Arginine—ARG2—blood—hematologic cancer	0.00294	0.0279	CbGeAlD
L-Arginine—SLC7A1—testis—hematologic cancer	0.00284	0.027	CbGeAlD
L-Arginine—ARG2—lung—hematologic cancer	0.00258	0.0245	CbGeAlD
L-Arginine—ARG2—testis—hematologic cancer	0.00243	0.0231	CbGeAlD
L-Arginine—ASS1—gonad—hematologic cancer	0.00236	0.0225	CbGeAlD
L-Arginine—SLC16A10—hematopoietic system—hematologic cancer	0.00222	0.0211	CbGeAlD
L-Arginine—SLC7A1—lymph node—hematologic cancer	0.00206	0.0196	CbGeAlD
L-Arginine—ASS1—blood—hematologic cancer	0.00206	0.0196	CbGeAlD
L-Arginine—NOS3—blood—hematologic cancer	0.00205	0.0195	CbGeAlD
L-Arginine—L-Asparagine—ASNS—hematologic cancer	0.00193	0.216	CrCbGaD
L-Arginine—L-Glutamine—TGM6—hematologic cancer	0.00182	0.204	CrCbGaD
L-Arginine—L-Glutamine—GMPS—hematologic cancer	0.00182	0.204	CrCbGaD
L-Arginine—ASS1—lung—hematologic cancer	0.00181	0.0172	CbGeAlD
L-Arginine—NOS3—lung—hematologic cancer	0.0018	0.0171	CbGeAlD
L-Arginine—ARG2—lymph node—hematologic cancer	0.00176	0.0167	CbGeAlD
L-Arginine—ASS1—testis—hematologic cancer	0.0017	0.0162	CbGeAlD
L-Arginine—NOS3—testis—hematologic cancer	0.0017	0.0161	CbGeAlD
L-Arginine—SLC16A10—gonad—hematologic cancer	0.00169	0.016	CbGeAlD
L-Arginine—SLC16A10—blood—hematologic cancer	0.00147	0.014	CbGeAlD
L-Arginine—SLC22A4—blood—hematologic cancer	0.00131	0.0124	CbGeAlD
L-Arginine—SLC16A10—lung—hematologic cancer	0.00129	0.0123	CbGeAlD
L-Arginine—SLC22A4—bone marrow—hematologic cancer	0.00127	0.012	CbGeAlD
L-Arginine—ASS1—lymph node—hematologic cancer	0.00124	0.0117	CbGeAlD
L-Arginine—NOS3—lymph node—hematologic cancer	0.00123	0.0117	CbGeAlD
L-Arginine—SLC16A10—testis—hematologic cancer	0.00122	0.0116	CbGeAlD
L-Arginine—L-Cysteine—MGMT—hematologic cancer	0.00121	0.136	CrCbGaD
L-Arginine—SLC22A4—lung—hematologic cancer	0.00115	0.0109	CbGeAlD
L-Arginine—L-Glutamine—ASNS—hematologic cancer	0.00104	0.117	CrCbGaD
L-Arginine—SLC16A10—lymph node—hematologic cancer	0.000883	0.00838	CbGeAlD
L-Arginine—SLC22A5—blood—hematologic cancer	0.000868	0.00824	CbGeAlD
L-Arginine—L-Methionine—MTR—hematologic cancer	0.000824	0.0924	CrCbGaD
L-Arginine—SLC22A4—lymph node—hematologic cancer	0.000786	0.00746	CbGeAlD
L-Arginine—SLC22A5—lung—hematologic cancer	0.000761	0.00722	CbGeAlD
L-Arginine—SLC22A5—testis—hematologic cancer	0.000718	0.00681	CbGeAlD
L-Arginine—SLC22A5—lymph node—hematologic cancer	0.00052	0.00494	CbGeAlD
L-Arginine—L-Methionine—MTHFR—hematologic cancer	0.000282	0.0316	CrCbGaD
L-Arginine—Anaphylactic shock—Vincristine—hematologic cancer	0.000197	0.00079	CcSEcCtD
L-Arginine—Anorexia—Carmustine—hematologic cancer	0.000197	0.000789	CcSEcCtD
L-Arginine—Hypersensitivity—Melphalan—hematologic cancer	0.000196	0.000786	CcSEcCtD
L-Arginine—Nausea—Procarbazine—hematologic cancer	0.000196	0.000785	CcSEcCtD
L-Arginine—Hyperhidrosis—Ifosfamide—hematologic cancer	0.000195	0.000783	CcSEcCtD
L-Arginine—Anorexia—Alitretinoin—hematologic cancer	0.000195	0.000781	CcSEcCtD
L-Arginine—Vomiting—Chlorambucil—hematologic cancer	0.000194	0.000779	CcSEcCtD
L-Arginine—Decreased appetite—Thiotepa—hematologic cancer	0.000193	0.000774	CcSEcCtD
L-Arginine—Anorexia—Ifosfamide—hematologic cancer	0.000193	0.000772	CcSEcCtD
L-Arginine—Nausea—Dasatinib—hematologic cancer	0.000192	0.00077	CcSEcCtD
L-Arginine—Nausea—Bexarotene—hematologic cancer	0.000192	0.00077	CcSEcCtD
L-Arginine—Anaphylactic shock—Mitoxantrone—hematologic cancer	0.000192	0.000769	CcSEcCtD
L-Arginine—Anaphylactic shock—Irinotecan—hematologic cancer	0.000192	0.000769	CcSEcCtD
L-Arginine—Nausea—Fludarabine—hematologic cancer	0.000192	0.000768	CcSEcCtD
L-Arginine—Hypersensitivity—Lenalidomide—hematologic cancer	0.000191	0.000765	CcSEcCtD
L-Arginine—Hyperhidrosis—Vincristine—hematologic cancer	0.000191	0.000763	CcSEcCtD
L-Arginine—Vomiting—Nilotinib—hematologic cancer	0.00019	0.000761	CcSEcCtD
L-Arginine—Vomiting—Imatinib—hematologic cancer	0.000189	0.000757	CcSEcCtD
L-Arginine—Rash—Nilotinib—hematologic cancer	0.000189	0.000755	CcSEcCtD
L-Arginine—Dermatitis—Nilotinib—hematologic cancer	0.000188	0.000754	CcSEcCtD
L-Arginine—Hypersensitivity—Hydroxyurea—hematologic cancer	0.000188	0.000754	CcSEcCtD
L-Arginine—Anorexia—Vincristine—hematologic cancer	0.000188	0.000753	CcSEcCtD
L-Arginine—Rash—Imatinib—hematologic cancer	0.000187	0.000751	CcSEcCtD
L-Arginine—Tachycardia—Mitoxantrone—hematologic cancer	0.000187	0.000751	CcSEcCtD
L-Arginine—Headache—Nilotinib—hematologic cancer	0.000187	0.00075	CcSEcCtD
L-Arginine—Dermatitis—Imatinib—hematologic cancer	0.000187	0.00075	CcSEcCtD
L-Arginine—Anaphylactic shock—Gemcitabine—hematologic cancer	0.000187	0.000749	CcSEcCtD
L-Arginine—Decreased appetite—Thalidomide—hematologic cancer	0.000187	0.000749	CcSEcCtD
L-Arginine—Headache—Imatinib—hematologic cancer	0.000186	0.000746	CcSEcCtD
L-Arginine—Lethargy—Epirubicin—hematologic cancer	0.000186	0.000745	CcSEcCtD
L-Arginine—Vomiting—Cladribine—hematologic cancer	0.000186	0.000744	CcSEcCtD
L-Arginine—Hyperhidrosis—Mitoxantrone—hematologic cancer	0.000186	0.000744	CcSEcCtD
L-Arginine—Hyperhidrosis—Irinotecan—hematologic cancer	0.000186	0.000744	CcSEcCtD
L-Arginine—Rash—Cladribine—hematologic cancer	0.000184	0.000738	CcSEcCtD
L-Arginine—Dermatitis—Cladribine—hematologic cancer	0.000184	0.000737	CcSEcCtD
L-Arginine—Anorexia—Irinotecan—hematologic cancer	0.000183	0.000733	CcSEcCtD
L-Arginine—Anorexia—Mitoxantrone—hematologic cancer	0.000183	0.000733	CcSEcCtD
L-Arginine—Headache—Cladribine—hematologic cancer	0.000183	0.000733	CcSEcCtD
L-Arginine—Nausea—Chlorambucil—hematologic cancer	0.000182	0.000727	CcSEcCtD
L-Arginine—Hyperhidrosis—Gemcitabine—hematologic cancer	0.000181	0.000724	CcSEcCtD
L-Arginine—Decreased appetite—Carmustine—hematologic cancer	0.00018	0.000719	CcSEcCtD
L-Arginine—Anorexia—Gemcitabine—hematologic cancer	0.000178	0.000714	CcSEcCtD
L-Arginine—Vomiting—Vinblastine—hematologic cancer	0.000178	0.000713	CcSEcCtD
L-Arginine—Decreased appetite—Alitretinoin—hematologic cancer	0.000178	0.000712	CcSEcCtD
L-Arginine—Nausea—Nilotinib—hematologic cancer	0.000178	0.000711	CcSEcCtD
L-Arginine—Nausea—Imatinib—hematologic cancer	0.000177	0.000707	CcSEcCtD
L-Arginine—Decreased appetite—Ifosfamide—hematologic cancer	0.000176	0.000704	CcSEcCtD
L-Arginine—Hypersensitivity—Bortezomib—hematologic cancer	0.000176	0.000704	CcSEcCtD
L-Arginine—Headache—Vinblastine—hematologic cancer	0.000175	0.000703	CcSEcCtD
L-Arginine—Anaphylactic shock—Cisplatin—hematologic cancer	0.000174	0.000698	CcSEcCtD
L-Arginine—Hypersensitivity—Bleomycin—hematologic cancer	0.000174	0.000698	CcSEcCtD
L-Arginine—Nausea—Cladribine—hematologic cancer	0.000174	0.000695	CcSEcCtD
L-Arginine—Lethargy—Doxorubicin—hematologic cancer	0.000172	0.000689	CcSEcCtD
L-Arginine—Hypersensitivity—Vinorelbine—hematologic cancer	0.000172	0.000687	CcSEcCtD
L-Arginine—Decreased appetite—Vincristine—hematologic cancer	0.000171	0.000687	CcSEcCtD
L-Arginine—Tachycardia—Cisplatin—hematologic cancer	0.00017	0.000682	CcSEcCtD
L-Arginine—Vomiting—Melphalan—hematologic cancer	0.000169	0.000679	CcSEcCtD
L-Arginine—Hyperhidrosis—Cisplatin—hematologic cancer	0.000169	0.000675	CcSEcCtD
L-Arginine—Rash—Melphalan—hematologic cancer	0.000168	0.000673	CcSEcCtD
L-Arginine—Dermatitis—Melphalan—hematologic cancer	0.000168	0.000672	CcSEcCtD
L-Arginine—Decreased appetite—Mitoxantrone—hematologic cancer	0.000167	0.000669	CcSEcCtD
L-Arginine—Decreased appetite—Irinotecan—hematologic cancer	0.000167	0.000669	CcSEcCtD
L-Arginine—Nausea—Vinblastine—hematologic cancer	0.000166	0.000667	CcSEcCtD
L-Arginine—Anorexia—Cisplatin—hematologic cancer	0.000166	0.000666	CcSEcCtD
L-Arginine—Vomiting—Lenalidomide—hematologic cancer	0.000165	0.00066	CcSEcCtD
L-Arginine—Hypersensitivity—Thiotepa—hematologic cancer	0.000164	0.000656	CcSEcCtD
L-Arginine—Rash—Lenalidomide—hematologic cancer	0.000163	0.000654	CcSEcCtD
L-Arginine—Dermatitis—Lenalidomide—hematologic cancer	0.000163	0.000654	CcSEcCtD
L-Arginine—Decreased appetite—Gemcitabine—hematologic cancer	0.000163	0.000651	CcSEcCtD
L-Arginine—Vomiting—Hydroxyurea—hematologic cancer	0.000162	0.000651	CcSEcCtD
L-Arginine—Headache—Lenalidomide—hematologic cancer	0.000162	0.00065	CcSEcCtD
L-Arginine—Rash—Hydroxyurea—hematologic cancer	0.000161	0.000645	CcSEcCtD
L-Arginine—Dermatitis—Hydroxyurea—hematologic cancer	0.000161	0.000645	CcSEcCtD
L-Arginine—Headache—Hydroxyurea—hematologic cancer	0.00016	0.000641	CcSEcCtD
L-Arginine—Anaphylactic shock—Etoposide—hematologic cancer	0.00016	0.00064	CcSEcCtD
L-Arginine—Hypersensitivity—Thalidomide—hematologic cancer	0.000158	0.000635	CcSEcCtD
L-Arginine—Nausea—Melphalan—hematologic cancer	0.000158	0.000634	CcSEcCtD
L-Arginine—Anaphylactic shock—Prednisolone—hematologic cancer	0.000158	0.000631	CcSEcCtD
L-Arginine—Tachycardia—Etoposide—hematologic cancer	0.000156	0.000624	CcSEcCtD
L-Arginine—Hyperhidrosis—Etoposide—hematologic cancer	0.000154	0.000618	CcSEcCtD
L-Arginine—Nausea—Lenalidomide—hematologic cancer	0.000154	0.000616	CcSEcCtD
L-Arginine—Tachycardia—Prednisolone—hematologic cancer	0.000154	0.000616	CcSEcCtD
L-Arginine—Hyperhidrosis—Prednisolone—hematologic cancer	0.000152	0.00061	CcSEcCtD
L-Arginine—Anorexia—Etoposide—hematologic cancer	0.000152	0.00061	CcSEcCtD
L-Arginine—Hypersensitivity—Carmustine—hematologic cancer	0.000152	0.00061	CcSEcCtD
L-Arginine—Nausea—Hydroxyurea—hematologic cancer	0.000152	0.000608	CcSEcCtD
L-Arginine—Vomiting—Bortezomib—hematologic cancer	0.000152	0.000607	CcSEcCtD
L-Arginine—Decreased appetite—Cisplatin—hematologic cancer	0.000152	0.000607	CcSEcCtD
L-Arginine—Hypersensitivity—Alitretinoin—hematologic cancer	0.000151	0.000604	CcSEcCtD
L-Arginine—Vomiting—Bleomycin—hematologic cancer	0.00015	0.000603	CcSEcCtD
L-Arginine—Rash—Bortezomib—hematologic cancer	0.00015	0.000602	CcSEcCtD
L-Arginine—Dermatitis—Bortezomib—hematologic cancer	0.00015	0.000602	CcSEcCtD
L-Arginine—Flushing—Prednisone—hematologic cancer	0.00015	0.000599	CcSEcCtD
L-Arginine—Headache—Bortezomib—hematologic cancer	0.000149	0.000598	CcSEcCtD
L-Arginine—Rash—Bleomycin—hematologic cancer	0.000149	0.000598	CcSEcCtD
L-Arginine—Dermatitis—Bleomycin—hematologic cancer	0.000149	0.000597	CcSEcCtD
L-Arginine—Hypersensitivity—Ifosfamide—hematologic cancer	0.000149	0.000597	CcSEcCtD
L-Arginine—Vomiting—Vinorelbine—hematologic cancer	0.000148	0.000593	CcSEcCtD
L-Arginine—Rash—Vinorelbine—hematologic cancer	0.000147	0.000588	CcSEcCtD
L-Arginine—Dermatitis—Vinorelbine—hematologic cancer	0.000147	0.000587	CcSEcCtD
L-Arginine—Headache—Vinorelbine—hematologic cancer	0.000146	0.000584	CcSEcCtD
L-Arginine—Hypersensitivity—Vincristine—hematologic cancer	0.000145	0.000582	CcSEcCtD
L-Arginine—Anaphylactic shock—Triamcinolone—hematologic cancer	0.000145	0.00058	CcSEcCtD
L-Arginine—Sweating—Methotrexate—hematologic cancer	0.000144	0.000576	CcSEcCtD
L-Arginine—Haematuria—Methotrexate—hematologic cancer	0.000143	0.000573	CcSEcCtD
L-Arginine—Nausea—Bortezomib—hematologic cancer	0.000142	0.000567	CcSEcCtD
L-Arginine—Hypersensitivity—Irinotecan—hematologic cancer	0.000141	0.000567	CcSEcCtD
L-Arginine—Hypersensitivity—Mitoxantrone—hematologic cancer	0.000141	0.000567	CcSEcCtD
L-Arginine—Tachycardia—Triamcinolone—hematologic cancer	0.000141	0.000566	CcSEcCtD
L-Arginine—Vomiting—Thiotepa—hematologic cancer	0.000141	0.000566	CcSEcCtD
L-Arginine—Nausea—Bleomycin—hematologic cancer	0.000141	0.000563	CcSEcCtD
L-Arginine—Rash—Thiotepa—hematologic cancer	0.00014	0.000562	CcSEcCtD
L-Arginine—Dermatitis—Thiotepa—hematologic cancer	0.00014	0.000561	CcSEcCtD
L-Arginine—Hyperhidrosis—Triamcinolone—hematologic cancer	0.00014	0.000561	CcSEcCtD
L-Arginine—Headache—Thiotepa—hematologic cancer	0.000139	0.000558	CcSEcCtD
L-Arginine—Decreased appetite—Etoposide—hematologic cancer	0.000139	0.000556	CcSEcCtD
L-Arginine—Nausea—Vinorelbine—hematologic cancer	0.000138	0.000554	CcSEcCtD
L-Arginine—Vomiting—Thalidomide—hematologic cancer	0.000137	0.000548	CcSEcCtD
L-Arginine—Rash—Thalidomide—hematologic cancer	0.000136	0.000543	CcSEcCtD
L-Arginine—Dermatitis—Thalidomide—hematologic cancer	0.000135	0.000543	CcSEcCtD
L-Arginine—Headache—Thalidomide—hematologic cancer	0.000135	0.00054	CcSEcCtD
L-Arginine—Sweating—Epirubicin—hematologic cancer	0.000135	0.000539	CcSEcCtD
L-Arginine—Haematuria—Epirubicin—hematologic cancer	0.000134	0.000536	CcSEcCtD
L-Arginine—Nausea—Thiotepa—hematologic cancer	0.000132	0.000529	CcSEcCtD
L-Arginine—Anaphylactic shock—Dexamethasone—hematologic cancer	0.000131	0.000527	CcSEcCtD
L-Arginine—Anaphylactic shock—Betamethasone—hematologic cancer	0.000131	0.000527	CcSEcCtD
L-Arginine—Vomiting—Carmustine—hematologic cancer	0.000131	0.000526	CcSEcCtD
L-Arginine—Rash—Carmustine—hematologic cancer	0.00013	0.000522	CcSEcCtD
L-Arginine—Dermatitis—Carmustine—hematologic cancer	0.00013	0.000521	CcSEcCtD
L-Arginine—Vomiting—Alitretinoin—hematologic cancer	0.00013	0.000521	CcSEcCtD
L-Arginine—Headache—Carmustine—hematologic cancer	0.000129	0.000518	CcSEcCtD
L-Arginine—Rash—Alitretinoin—hematologic cancer	0.000129	0.000517	CcSEcCtD
L-Arginine—Dermatitis—Alitretinoin—hematologic cancer	0.000129	0.000516	CcSEcCtD
L-Arginine—Vomiting—Ifosfamide—hematologic cancer	0.000129	0.000515	CcSEcCtD
L-Arginine—Hypersensitivity—Cisplatin—hematologic cancer	0.000128	0.000514	CcSEcCtD
L-Arginine—Tachycardia—Betamethasone—hematologic cancer	0.000128	0.000514	CcSEcCtD
L-Arginine—Tachycardia—Dexamethasone—hematologic cancer	0.000128	0.000514	CcSEcCtD
L-Arginine—Headache—Alitretinoin—hematologic cancer	0.000128	0.000513	CcSEcCtD
L-Arginine—Nausea—Thalidomide—hematologic cancer	0.000128	0.000512	CcSEcCtD
L-Arginine—Rash—Ifosfamide—hematologic cancer	0.000127	0.000511	CcSEcCtD
L-Arginine—Dermatitis—Ifosfamide—hematologic cancer	0.000127	0.00051	CcSEcCtD
L-Arginine—Hyperhidrosis—Betamethasone—hematologic cancer	0.000127	0.000509	CcSEcCtD
L-Arginine—Hyperhidrosis—Dexamethasone—hematologic cancer	0.000127	0.000509	CcSEcCtD
L-Arginine—Hypoaesthesia—Epirubicin—hematologic cancer	0.000125	0.000502	CcSEcCtD
L-Arginine—Vomiting—Vincristine—hematologic cancer	0.000125	0.000502	CcSEcCtD
L-Arginine—Anorexia—Dexamethasone—hematologic cancer	0.000125	0.000502	CcSEcCtD
L-Arginine—Anorexia—Betamethasone—hematologic cancer	0.000125	0.000502	CcSEcCtD
L-Arginine—Sweating—Doxorubicin—hematologic cancer	0.000125	0.000499	CcSEcCtD
L-Arginine—Rash—Vincristine—hematologic cancer	0.000124	0.000498	CcSEcCtD
L-Arginine—Dermatitis—Vincristine—hematologic cancer	0.000124	0.000497	CcSEcCtD
L-Arginine—Haematuria—Doxorubicin—hematologic cancer	0.000124	0.000496	CcSEcCtD
L-Arginine—Headache—Vincristine—hematologic cancer	0.000124	0.000495	CcSEcCtD
L-Arginine—Nausea—Carmustine—hematologic cancer	0.000123	0.000491	CcSEcCtD
L-Arginine—Vomiting—Irinotecan—hematologic cancer	0.000122	0.000489	CcSEcCtD
L-Arginine—Vomiting—Mitoxantrone—hematologic cancer	0.000122	0.000489	CcSEcCtD
L-Arginine—Nausea—Alitretinoin—hematologic cancer	0.000122	0.000487	CcSEcCtD
L-Arginine—Rash—Mitoxantrone—hematologic cancer	0.000121	0.000485	CcSEcCtD
L-Arginine—Rash—Irinotecan—hematologic cancer	0.000121	0.000485	CcSEcCtD
L-Arginine—Dermatitis—Mitoxantrone—hematologic cancer	0.000121	0.000484	CcSEcCtD
L-Arginine—Dermatitis—Irinotecan—hematologic cancer	0.000121	0.000484	CcSEcCtD
L-Arginine—Headache—Mitoxantrone—hematologic cancer	0.00012	0.000482	CcSEcCtD
L-Arginine—Headache—Irinotecan—hematologic cancer	0.00012	0.000482	CcSEcCtD
L-Arginine—Nausea—Ifosfamide—hematologic cancer	0.00012	0.000481	CcSEcCtD
L-Arginine—Vomiting—Gemcitabine—hematologic cancer	0.000119	0.000476	CcSEcCtD
L-Arginine—Rash—Gemcitabine—hematologic cancer	0.000118	0.000472	CcSEcCtD
L-Arginine—Dermatitis—Gemcitabine—hematologic cancer	0.000118	0.000472	CcSEcCtD
L-Arginine—Hypersensitivity—Etoposide—hematologic cancer	0.000118	0.000471	CcSEcCtD
L-Arginine—Headache—Gemcitabine—hematologic cancer	0.000117	0.000469	CcSEcCtD
L-Arginine—Nausea—Vincristine—hematologic cancer	0.000117	0.000469	CcSEcCtD
L-Arginine—Flushing—Epirubicin—hematologic cancer	0.000117	0.000468	CcSEcCtD
L-Arginine—Hypersensitivity—Prednisolone—hematologic cancer	0.000116	0.000465	CcSEcCtD
L-Arginine—Hypoaesthesia—Doxorubicin—hematologic cancer	0.000116	0.000465	CcSEcCtD
L-Arginine—Anaphylactic shock—Prednisone—hematologic cancer	0.000114	0.000459	CcSEcCtD
L-Arginine—Decreased appetite—Dexamethasone—hematologic cancer	0.000114	0.000458	CcSEcCtD
L-Arginine—Decreased appetite—Betamethasone—hematologic cancer	0.000114	0.000458	CcSEcCtD
L-Arginine—Nausea—Irinotecan—hematologic cancer	0.000114	0.000457	CcSEcCtD
L-Arginine—Nausea—Mitoxantrone—hematologic cancer	0.000114	0.000457	CcSEcCtD
L-Arginine—Tachycardia—Prednisone—hematologic cancer	0.000112	0.000447	CcSEcCtD
L-Arginine—Nausea—Gemcitabine—hematologic cancer	0.000111	0.000445	CcSEcCtD
L-Arginine—Vomiting—Cisplatin—hematologic cancer	0.000111	0.000444	CcSEcCtD
L-Arginine—Hyperhidrosis—Prednisone—hematologic cancer	0.000111	0.000443	CcSEcCtD
L-Arginine—Rash—Cisplatin—hematologic cancer	0.00011	0.00044	CcSEcCtD
L-Arginine—Dermatitis—Cisplatin—hematologic cancer	0.00011	0.00044	CcSEcCtD
L-Arginine—Anorexia—Prednisone—hematologic cancer	0.000109	0.000437	CcSEcCtD
L-Arginine—Flushing—Doxorubicin—hematologic cancer	0.000108	0.000433	CcSEcCtD
L-Arginine—Hypersensitivity—Triamcinolone—hematologic cancer	0.000107	0.000428	CcSEcCtD
L-Arginine—Nausea—Cisplatin—hematologic cancer	0.000104	0.000415	CcSEcCtD
L-Arginine—Vomiting—Etoposide—hematologic cancer	0.000102	0.000407	CcSEcCtD
L-Arginine—Rash—Etoposide—hematologic cancer	0.000101	0.000403	CcSEcCtD
L-Arginine—Dermatitis—Etoposide—hematologic cancer	0.000101	0.000403	CcSEcCtD
L-Arginine—Headache—Etoposide—hematologic cancer	0.0001	0.000401	CcSEcCtD
L-Arginine—Decreased appetite—Prednisone—hematologic cancer	9.95e-05	0.000399	CcSEcCtD
L-Arginine—Rash—Prednisolone—hematologic cancer	9.93e-05	0.000398	CcSEcCtD
L-Arginine—Dermatitis—Prednisolone—hematologic cancer	9.92e-05	0.000397	CcSEcCtD
L-Arginine—Headache—Prednisolone—hematologic cancer	9.87e-05	0.000395	CcSEcCtD
L-Arginine—Anaphylactic shock—Methotrexate—hematologic cancer	9.57e-05	0.000383	CcSEcCtD
L-Arginine—Nausea—Etoposide—hematologic cancer	9.49e-05	0.00038	CcSEcCtD
L-Arginine—Nausea—Prednisolone—hematologic cancer	9.36e-05	0.000375	CcSEcCtD
L-Arginine—Hyperhidrosis—Methotrexate—hematologic cancer	9.25e-05	0.00037	CcSEcCtD
L-Arginine—Vomiting—Triamcinolone—hematologic cancer	9.21e-05	0.000369	CcSEcCtD
L-Arginine—Rash—Triamcinolone—hematologic cancer	9.13e-05	0.000366	CcSEcCtD
L-Arginine—Dermatitis—Triamcinolone—hematologic cancer	9.12e-05	0.000366	CcSEcCtD
L-Arginine—Anorexia—Methotrexate—hematologic cancer	9.12e-05	0.000365	CcSEcCtD
L-Arginine—Headache—Triamcinolone—hematologic cancer	9.07e-05	0.000364	CcSEcCtD
L-Arginine—Anaphylactic shock—Epirubicin—hematologic cancer	8.95e-05	0.000359	CcSEcCtD
L-Arginine—Tachycardia—Epirubicin—hematologic cancer	8.74e-05	0.00035	CcSEcCtD
L-Arginine—Hyperhidrosis—Epirubicin—hematologic cancer	8.65e-05	0.000347	CcSEcCtD
L-Arginine—Nausea—Triamcinolone—hematologic cancer	8.6e-05	0.000345	CcSEcCtD
L-Arginine—Anorexia—Epirubicin—hematologic cancer	8.53e-05	0.000342	CcSEcCtD
L-Arginine—Hypersensitivity—Prednisone—hematologic cancer	8.43e-05	0.000338	CcSEcCtD
L-Arginine—Vomiting—Dexamethasone—hematologic cancer	8.36e-05	0.000335	CcSEcCtD
L-Arginine—Vomiting—Betamethasone—hematologic cancer	8.36e-05	0.000335	CcSEcCtD
L-Arginine—Decreased appetite—Methotrexate—hematologic cancer	8.32e-05	0.000333	CcSEcCtD
L-Arginine—Rash—Dexamethasone—hematologic cancer	8.29e-05	0.000332	CcSEcCtD
L-Arginine—Rash—Betamethasone—hematologic cancer	8.29e-05	0.000332	CcSEcCtD
L-Arginine—Anaphylactic shock—Doxorubicin—hematologic cancer	8.28e-05	0.000332	CcSEcCtD
L-Arginine—Dermatitis—Dexamethasone—hematologic cancer	8.28e-05	0.000332	CcSEcCtD
L-Arginine—Dermatitis—Betamethasone—hematologic cancer	8.28e-05	0.000332	CcSEcCtD
L-Arginine—Headache—Betamethasone—hematologic cancer	8.23e-05	0.00033	CcSEcCtD
L-Arginine—Headache—Dexamethasone—hematologic cancer	8.23e-05	0.00033	CcSEcCtD
L-Arginine—Tachycardia—Doxorubicin—hematologic cancer	8.08e-05	0.000324	CcSEcCtD
L-Arginine—Hyperhidrosis—Doxorubicin—hematologic cancer	8.01e-05	0.000321	CcSEcCtD
L-Arginine—Anorexia—Doxorubicin—hematologic cancer	7.9e-05	0.000316	CcSEcCtD
L-Arginine—Nausea—Betamethasone—hematologic cancer	7.81e-05	0.000313	CcSEcCtD
L-Arginine—Nausea—Dexamethasone—hematologic cancer	7.81e-05	0.000313	CcSEcCtD
L-Arginine—Decreased appetite—Epirubicin—hematologic cancer	7.78e-05	0.000312	CcSEcCtD
L-Arginine—Vomiting—Prednisone—hematologic cancer	7.28e-05	0.000292	CcSEcCtD
L-Arginine—Rash—Prednisone—hematologic cancer	7.22e-05	0.000289	CcSEcCtD
L-Arginine—Dermatitis—Prednisone—hematologic cancer	7.21e-05	0.000289	CcSEcCtD
L-Arginine—Decreased appetite—Doxorubicin—hematologic cancer	7.2e-05	0.000288	CcSEcCtD
L-Arginine—Headache—Prednisone—hematologic cancer	7.17e-05	0.000287	CcSEcCtD
L-Arginine—Hypersensitivity—Methotrexate—hematologic cancer	7.05e-05	0.000282	CcSEcCtD
L-Arginine—Nausea—Prednisone—hematologic cancer	6.8e-05	0.000272	CcSEcCtD
L-Arginine—Hypersensitivity—Epirubicin—hematologic cancer	6.6e-05	0.000264	CcSEcCtD
L-Arginine—Hypersensitivity—Doxorubicin—hematologic cancer	6.1e-05	0.000244	CcSEcCtD
L-Arginine—Vomiting—Methotrexate—hematologic cancer	6.08e-05	0.000244	CcSEcCtD
L-Arginine—Rash—Methotrexate—hematologic cancer	6.03e-05	0.000242	CcSEcCtD
L-Arginine—Dermatitis—Methotrexate—hematologic cancer	6.03e-05	0.000241	CcSEcCtD
L-Arginine—Headache—Methotrexate—hematologic cancer	5.99e-05	0.00024	CcSEcCtD
L-Arginine—Vomiting—Epirubicin—hematologic cancer	5.69e-05	0.000228	CcSEcCtD
L-Arginine—Nausea—Methotrexate—hematologic cancer	5.68e-05	0.000228	CcSEcCtD
L-Arginine—Rash—Epirubicin—hematologic cancer	5.64e-05	0.000226	CcSEcCtD
L-Arginine—Dermatitis—Epirubicin—hematologic cancer	5.64e-05	0.000226	CcSEcCtD
L-Arginine—Headache—Epirubicin—hematologic cancer	5.61e-05	0.000225	CcSEcCtD
L-Arginine—Nausea—Epirubicin—hematologic cancer	5.32e-05	0.000213	CcSEcCtD
L-Arginine—Vomiting—Doxorubicin—hematologic cancer	5.27e-05	0.000211	CcSEcCtD
L-Arginine—Rash—Doxorubicin—hematologic cancer	5.22e-05	0.000209	CcSEcCtD
L-Arginine—Dermatitis—Doxorubicin—hematologic cancer	5.22e-05	0.000209	CcSEcCtD
L-Arginine—Headache—Doxorubicin—hematologic cancer	5.19e-05	0.000208	CcSEcCtD
L-Arginine—Nausea—Doxorubicin—hematologic cancer	4.92e-05	0.000197	CcSEcCtD
L-Arginine—NOS2—Disease—PDGFRB—hematologic cancer	2e-05	9.61e-05	CbGpPWpGaD
L-Arginine—NOS2—Hemostasis—EP300—hematologic cancer	1.99e-05	9.57e-05	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—RAC2—hematologic cancer	1.99e-05	9.54e-05	CbGpPWpGaD
L-Arginine—ASS1—Metabolism—ALB—hematologic cancer	1.98e-05	9.51e-05	CbGpPWpGaD
L-Arginine—NOS3—Hemostasis—JAK2—hematologic cancer	1.98e-05	9.49e-05	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—DKK1—hematologic cancer	1.97e-05	9.46e-05	CbGpPWpGaD
L-Arginine—NOS2—Disease—PDGFRA—hematologic cancer	1.97e-05	9.46e-05	CbGpPWpGaD
L-Arginine—NOS2—Disease—JAK1—hematologic cancer	1.96e-05	9.43e-05	CbGpPWpGaD
L-Arginine—NOS2—Disease—PRKCG—hematologic cancer	1.96e-05	9.43e-05	CbGpPWpGaD
L-Arginine—NOS3—Disease—HSP90AA1—hematologic cancer	1.96e-05	9.41e-05	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—STAT5B—hematologic cancer	1.95e-05	9.39e-05	CbGpPWpGaD
L-Arginine—NOS2—Hemostasis—SRC—hematologic cancer	1.94e-05	9.3e-05	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—ADCY7—hematologic cancer	1.9e-05	9.11e-05	CbGpPWpGaD
L-Arginine—ASS1—Metabolism—PIK3R1—hematologic cancer	1.89e-05	9.1e-05	CbGpPWpGaD
L-Arginine—NOS3—Disease—STAT1—hematologic cancer	1.89e-05	9.07e-05	CbGpPWpGaD
L-Arginine—NOS2—Hemostasis—VEGFA—hematologic cancer	1.89e-05	9.06e-05	CbGpPWpGaD
L-Arginine—NOS3—Hemostasis—PIK3CB—hematologic cancer	1.88e-05	9.02e-05	CbGpPWpGaD
L-Arginine—NOS2—Hemostasis—NRAS—hematologic cancer	1.86e-05	8.95e-05	CbGpPWpGaD
L-Arginine—ASL—Metabolism—PIK3CA—hematologic cancer	1.86e-05	8.91e-05	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—XIAP—hematologic cancer	1.85e-05	8.87e-05	CbGpPWpGaD
L-Arginine—NOS2—Disease—MTHFR—hematologic cancer	1.82e-05	8.73e-05	CbGpPWpGaD
L-Arginine—NOS2—Disease—HLA-A—hematologic cancer	1.81e-05	8.71e-05	CbGpPWpGaD
L-Arginine—NOS2—Disease—TERT—hematologic cancer	1.81e-05	8.71e-05	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—SH2B3—hematologic cancer	1.8e-05	8.64e-05	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—SMARCA4—hematologic cancer	1.8e-05	8.64e-05	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—GZMB—hematologic cancer	1.79e-05	8.59e-05	CbGpPWpGaD
L-Arginine—NOS2—Hemostasis—MAPK3—hematologic cancer	1.78e-05	8.57e-05	CbGpPWpGaD
L-Arginine—NOS2—Disease—PDGFB—hematologic cancer	1.77e-05	8.5e-05	CbGpPWpGaD
L-Arginine—NOS3—Disease—GRB2—hematologic cancer	1.77e-05	8.49e-05	CbGpPWpGaD
L-Arginine—NOS3—Disease—PDGFA—hematologic cancer	1.76e-05	8.47e-05	CbGpPWpGaD
L-Arginine—ASS1—Metabolism—PIK3CB—hematologic cancer	1.75e-05	8.4e-05	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—CTNNA1—hematologic cancer	1.75e-05	8.38e-05	CbGpPWpGaD
L-Arginine—NOS3—Metabolism—CD44—hematologic cancer	1.74e-05	8.38e-05	CbGpPWpGaD
L-Arginine—NOS3—Metabolism—NQO1—hematologic cancer	1.74e-05	8.38e-05	CbGpPWpGaD
L-Arginine—NOS3—Disease—KITLG—hematologic cancer	1.74e-05	8.35e-05	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—HSPB1—hematologic cancer	1.74e-05	8.34e-05	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—EIF4EBP1—hematologic cancer	1.74e-05	8.34e-05	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—CCL3—hematologic cancer	1.74e-05	8.34e-05	CbGpPWpGaD
L-Arginine—NOS2—Hemostasis—TGFB1—hematologic cancer	1.73e-05	8.32e-05	CbGpPWpGaD
L-Arginine—NOS2—Disease—TSC2—hematologic cancer	1.73e-05	8.31e-05	CbGpPWpGaD
L-Arginine—NOS3—Hemostasis—IL2—hematologic cancer	1.72e-05	8.28e-05	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—PTHLH—hematologic cancer	1.72e-05	8.24e-05	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—SDC1—hematologic cancer	1.72e-05	8.24e-05	CbGpPWpGaD
L-Arginine—NOS3—Disease—STAT5A—hematologic cancer	1.7e-05	8.16e-05	CbGpPWpGaD
L-Arginine—NOS3—Disease—CDKN2B—hematologic cancer	1.68e-05	8.09e-05	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—PTGER4—hematologic cancer	1.67e-05	8.02e-05	CbGpPWpGaD
L-Arginine—NOS2—Disease—FGFR3—hematologic cancer	1.66e-05	7.99e-05	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—LCK—hematologic cancer	1.66e-05	7.98e-05	CbGpPWpGaD
L-Arginine—SLC22A5—Transmembrane transport of small molecules—CREBBP—hematologic cancer	1.66e-05	7.96e-05	CbGpPWpGaD
L-Arginine—AZIN2—Metabolism—AKT1—hematologic cancer	1.66e-05	7.96e-05	CbGpPWpGaD
L-Arginine—NOS3—Metabolism—CYCS—hematologic cancer	1.65e-05	7.93e-05	CbGpPWpGaD
L-Arginine—NOS3—Metabolism—HSP90AA1—hematologic cancer	1.64e-05	7.88e-05	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—H3F3A—hematologic cancer	1.63e-05	7.83e-05	CbGpPWpGaD
L-Arginine—NOS3—Disease—CD86—hematologic cancer	1.63e-05	7.82e-05	CbGpPWpGaD
L-Arginine—NOS3—Disease—HES1—hematologic cancer	1.61e-05	7.72e-05	CbGpPWpGaD
L-Arginine—NOS2—Hemostasis—KRAS—hematologic cancer	1.6e-05	7.7e-05	CbGpPWpGaD
L-Arginine—NOS3—Disease—NCOR1—hematologic cancer	1.6e-05	7.67e-05	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—PRKCZ—hematologic cancer	1.58e-05	7.61e-05	CbGpPWpGaD
L-Arginine—NOS3—Disease—FGF1—hematologic cancer	1.58e-05	7.59e-05	CbGpPWpGaD
L-Arginine—NOS2—Disease—BAD—hematologic cancer	1.58e-05	7.57e-05	CbGpPWpGaD
L-Arginine—NOS2—Disease—NOTCH1—hematologic cancer	1.56e-05	7.5e-05	CbGpPWpGaD
L-Arginine—NOS3—Disease—FOXO1—hematologic cancer	1.56e-05	7.48e-05	CbGpPWpGaD
L-Arginine—NOS3—Disease—PDGFRB—hematologic cancer	1.55e-05	7.46e-05	CbGpPWpGaD
L-Arginine—SLC22A5—Transmembrane transport of small molecules—ALB—hematologic cancer	1.55e-05	7.45e-05	CbGpPWpGaD
L-Arginine—NOS3—Hemostasis—EP300—hematologic cancer	1.55e-05	7.43e-05	CbGpPWpGaD
L-Arginine—ARG2—Metabolism—PIK3CA—hematologic cancer	1.54e-05	7.39e-05	CbGpPWpGaD
L-Arginine—NOS2—Disease—CD80—hematologic cancer	1.53e-05	7.35e-05	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—PARP1—hematologic cancer	1.53e-05	7.35e-05	CbGpPWpGaD
L-Arginine—NOS3—Disease—PDGFRA—hematologic cancer	1.53e-05	7.35e-05	CbGpPWpGaD
L-Arginine—NOS2—Disease—KIT—hematologic cancer	1.53e-05	7.34e-05	CbGpPWpGaD
L-Arginine—NOS3—Disease—PRKCG—hematologic cancer	1.52e-05	7.32e-05	CbGpPWpGaD
L-Arginine—NOS3—Disease—JAK1—hematologic cancer	1.52e-05	7.32e-05	CbGpPWpGaD
L-Arginine—ASL—Metabolism—AKT1—hematologic cancer	1.52e-05	7.28e-05	CbGpPWpGaD
L-Arginine—ASS1—Metabolism—PTEN—hematologic cancer	1.51e-05	7.26e-05	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—FBXW7—hematologic cancer	1.5e-05	7.23e-05	CbGpPWpGaD
L-Arginine—NOS3—Hemostasis—SRC—hematologic cancer	1.5e-05	7.22e-05	CbGpPWpGaD
L-Arginine—NOS2—Disease—PTPN11—hematologic cancer	1.5e-05	7.21e-05	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—HDAC2—hematologic cancer	1.48e-05	7.09e-05	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—CXCR4—hematologic cancer	1.48e-05	7.09e-05	CbGpPWpGaD
L-Arginine—NOS2—Hemostasis—PIK3CA—hematologic cancer	1.47e-05	7.08e-05	CbGpPWpGaD
L-Arginine—NOS3—Hemostasis—VEGFA—hematologic cancer	1.46e-05	7.04e-05	CbGpPWpGaD
L-Arginine—NOS3—Metabolism—GSTP1—hematologic cancer	1.46e-05	6.99e-05	CbGpPWpGaD
L-Arginine—NOS2—Disease—CREB1—hematologic cancer	1.45e-05	6.98e-05	CbGpPWpGaD
L-Arginine—NOS3—Hemostasis—NRAS—hematologic cancer	1.45e-05	6.95e-05	CbGpPWpGaD
L-Arginine—ASS1—Metabolism—EP300—hematologic cancer	1.44e-05	6.92e-05	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—CBL—hematologic cancer	1.44e-05	6.91e-05	CbGpPWpGaD
L-Arginine—NOS2—Disease—BRAF—hematologic cancer	1.44e-05	6.9e-05	CbGpPWpGaD
L-Arginine—NOS2—Hemostasis—TP53—hematologic cancer	1.43e-05	6.85e-05	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—IL3—hematologic cancer	1.42e-05	6.84e-05	CbGpPWpGaD
L-Arginine—NOS2—Disease—IL6R—hematologic cancer	1.42e-05	6.81e-05	CbGpPWpGaD
L-Arginine—NOS2—Disease—CREBBP—hematologic cancer	1.42e-05	6.8e-05	CbGpPWpGaD
L-Arginine—NOS3—Disease—MTHFR—hematologic cancer	1.41e-05	6.78e-05	CbGpPWpGaD
L-Arginine—NOS3—Disease—HLA-A—hematologic cancer	1.41e-05	6.76e-05	CbGpPWpGaD
L-Arginine—NOS3—Disease—TERT—hematologic cancer	1.41e-05	6.76e-05	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—PTPN1—hematologic cancer	1.4e-05	6.72e-05	CbGpPWpGaD
L-Arginine—NOS3—Hemostasis—MAPK3—hematologic cancer	1.39e-05	6.66e-05	CbGpPWpGaD
L-Arginine—NOS3—Metabolism—ABCB1—hematologic cancer	1.38e-05	6.62e-05	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—RASGRP1—hematologic cancer	1.38e-05	6.61e-05	CbGpPWpGaD
L-Arginine—NOS3—Disease—PDGFB—hematologic cancer	1.37e-05	6.6e-05	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—SYK—hematologic cancer	1.37e-05	6.59e-05	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—HSP90AA1—hematologic cancer	1.37e-05	6.59e-05	CbGpPWpGaD
L-Arginine—NOS2—Hemostasis—HRAS—hematologic cancer	1.36e-05	6.55e-05	CbGpPWpGaD
L-Arginine—NOS2—Disease—MAP2K1—hematologic cancer	1.35e-05	6.49e-05	CbGpPWpGaD
L-Arginine—NOS3—Hemostasis—TGFB1—hematologic cancer	1.34e-05	6.46e-05	CbGpPWpGaD
L-Arginine—NOS3—Disease—TSC2—hematologic cancer	1.34e-05	6.45e-05	CbGpPWpGaD
L-Arginine—NOS2—Disease—PIK3CD—hematologic cancer	1.34e-05	6.45e-05	CbGpPWpGaD
L-Arginine—NOS3—Metabolism—GSTM1—hematologic cancer	1.34e-05	6.42e-05	CbGpPWpGaD
L-Arginine—NOS3—Metabolism—NCOR1—hematologic cancer	1.34e-05	6.42e-05	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—STAT1—hematologic cancer	1.32e-05	6.35e-05	CbGpPWpGaD
L-Arginine—NOS3—Disease—FGFR3—hematologic cancer	1.29e-05	6.2e-05	CbGpPWpGaD
L-Arginine—NOS2—Disease—FGF2—hematologic cancer	1.29e-05	6.17e-05	CbGpPWpGaD
L-Arginine—NOS2—Disease—PIK3R1—hematologic cancer	1.27e-05	6.09e-05	CbGpPWpGaD
L-Arginine—ARG2—Metabolism—AKT1—hematologic cancer	1.26e-05	6.03e-05	CbGpPWpGaD
L-Arginine—NOS3—Hemostasis—KRAS—hematologic cancer	1.25e-05	5.98e-05	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—GRB2—hematologic cancer	1.24e-05	5.94e-05	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—PDGFA—hematologic cancer	1.23e-05	5.93e-05	CbGpPWpGaD
L-Arginine—NOS2—Disease—JAK2—hematologic cancer	1.23e-05	5.92e-05	CbGpPWpGaD
L-Arginine—NOS3—Disease—BAD—hematologic cancer	1.22e-05	5.88e-05	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—KITLG—hematologic cancer	1.22e-05	5.85e-05	CbGpPWpGaD
L-Arginine—NOS3—Disease—NOTCH1—hematologic cancer	1.21e-05	5.82e-05	CbGpPWpGaD
L-Arginine—NOS2—Hemostasis—AKT1—hematologic cancer	1.2e-05	5.78e-05	CbGpPWpGaD
L-Arginine—NOS2—Disease—MDM2—hematologic cancer	1.2e-05	5.78e-05	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—STAT5A—hematologic cancer	1.19e-05	5.71e-05	CbGpPWpGaD
L-Arginine—NOS3—Disease—CD80—hematologic cancer	1.19e-05	5.71e-05	CbGpPWpGaD
L-Arginine—NOS3—Disease—KIT—hematologic cancer	1.19e-05	5.7e-05	CbGpPWpGaD
L-Arginine—NOS3—Metabolism—MTHFR—hematologic cancer	1.18e-05	5.68e-05	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—CDKN2B—hematologic cancer	1.18e-05	5.66e-05	CbGpPWpGaD
L-Arginine—NOS2—Disease—MTOR—hematologic cancer	1.17e-05	5.62e-05	CbGpPWpGaD
L-Arginine—NOS2—Disease—PIK3CB—hematologic cancer	1.17e-05	5.62e-05	CbGpPWpGaD
L-Arginine—NOS2—Disease—CD4—hematologic cancer	1.17e-05	5.61e-05	CbGpPWpGaD
L-Arginine—NOS3—Disease—PTPN11—hematologic cancer	1.16e-05	5.6e-05	CbGpPWpGaD
L-Arginine—NOS3—Hemostasis—PIK3CA—hematologic cancer	1.14e-05	5.5e-05	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—CD86—hematologic cancer	1.14e-05	5.48e-05	CbGpPWpGaD
L-Arginine—NOS3—Disease—CREB1—hematologic cancer	1.13e-05	5.42e-05	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—HES1—hematologic cancer	1.12e-05	5.4e-05	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—NCOR1—hematologic cancer	1.12e-05	5.37e-05	CbGpPWpGaD
L-Arginine—NOS3—Disease—BRAF—hematologic cancer	1.11e-05	5.35e-05	CbGpPWpGaD
L-Arginine—NOS3—Hemostasis—TP53—hematologic cancer	1.11e-05	5.32e-05	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—CSF2—hematologic cancer	1.11e-05	5.31e-05	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—FGF1—hematologic cancer	1.11e-05	5.31e-05	CbGpPWpGaD
L-Arginine—NOS3—Disease—IL6R—hematologic cancer	1.1e-05	5.29e-05	CbGpPWpGaD
L-Arginine—NOS3—Disease—CREBBP—hematologic cancer	1.1e-05	5.28e-05	CbGpPWpGaD
L-Arginine—NOS2—Disease—CDKN1B—hematologic cancer	1.1e-05	5.28e-05	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—FOXO1—hematologic cancer	1.09e-05	5.24e-05	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—PDGFRB—hematologic cancer	1.09e-05	5.23e-05	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—PDGFRA—hematologic cancer	1.07e-05	5.14e-05	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—JAK1—hematologic cancer	1.07e-05	5.13e-05	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—PRKCG—hematologic cancer	1.07e-05	5.13e-05	CbGpPWpGaD
L-Arginine—ASS1—Metabolism—PIK3CA—hematologic cancer	1.07e-05	5.12e-05	CbGpPWpGaD
L-Arginine—NOS3—Hemostasis—HRAS—hematologic cancer	1.06e-05	5.08e-05	CbGpPWpGaD
L-Arginine—NOS3—Disease—MAP2K1—hematologic cancer	1.05e-05	5.04e-05	CbGpPWpGaD
L-Arginine—NOS3—Disease—PIK3CD—hematologic cancer	1.04e-05	5.01e-05	CbGpPWpGaD
L-Arginine—NOS2—Disease—CDKN1A—hematologic cancer	1.01e-05	4.87e-05	CbGpPWpGaD
L-Arginine—NOS2—Disease—PTEN—hematologic cancer	1.01e-05	4.86e-05	CbGpPWpGaD
L-Arginine—NOS3—Disease—FGF2—hematologic cancer	9.98e-06	4.79e-05	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—IL2RA—hematologic cancer	9.97e-06	4.79e-05	CbGpPWpGaD
L-Arginine—NOS3—Metabolism—PIK3CG—hematologic cancer	9.93e-06	4.77e-05	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—TERT—hematologic cancer	9.86e-06	4.73e-05	CbGpPWpGaD
L-Arginine—NOS3—Disease—PIK3R1—hematologic cancer	9.84e-06	4.73e-05	CbGpPWpGaD
L-Arginine—NOS2—Disease—EP300—hematologic cancer	9.64e-06	4.63e-05	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—PDGFB—hematologic cancer	9.62e-06	4.62e-05	CbGpPWpGaD
L-Arginine—NOS3—Disease—JAK2—hematologic cancer	9.57e-06	4.6e-05	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—TSC2—hematologic cancer	9.4e-06	4.52e-05	CbGpPWpGaD
L-Arginine—NOS2—Disease—SRC—hematologic cancer	9.38e-06	4.5e-05	CbGpPWpGaD
L-Arginine—NOS3—Hemostasis—AKT1—hematologic cancer	9.35e-06	4.49e-05	CbGpPWpGaD
L-Arginine—NOS3—Disease—MDM2—hematologic cancer	9.34e-06	4.49e-05	CbGpPWpGaD
L-Arginine—NOS3—Metabolism—CREBBP—hematologic cancer	9.21e-06	4.42e-05	CbGpPWpGaD
L-Arginine—NOS3—Disease—MTOR—hematologic cancer	9.09e-06	4.36e-05	CbGpPWpGaD
L-Arginine—NOS3—Disease—PIK3CB—hematologic cancer	9.09e-06	4.36e-05	CbGpPWpGaD
L-Arginine—NOS3—Disease—CD4—hematologic cancer	9.07e-06	4.36e-05	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—FGFR3—hematologic cancer	9.04e-06	4.34e-05	CbGpPWpGaD
L-Arginine—NOS2—Disease—STAT3—hematologic cancer	9.04e-06	4.34e-05	CbGpPWpGaD
L-Arginine—NOS2—Disease—NRAS—hematologic cancer	9.02e-06	4.33e-05	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—MAPK14—hematologic cancer	8.95e-06	4.3e-05	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—ESR1—hematologic cancer	8.78e-06	4.22e-05	CbGpPWpGaD
L-Arginine—NOS3—Metabolism—PIK3CD—hematologic cancer	8.73e-06	4.19e-05	CbGpPWpGaD
L-Arginine—ASS1—Metabolism—AKT1—hematologic cancer	8.71e-06	4.18e-05	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—FN1—hematologic cancer	8.68e-06	4.17e-05	CbGpPWpGaD
L-Arginine—NOS2—Disease—MAPK3—hematologic cancer	8.64e-06	4.15e-05	CbGpPWpGaD
L-Arginine—NOS3—Metabolism—ALB—hematologic cancer	8.62e-06	4.14e-05	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—BAD—hematologic cancer	8.57e-06	4.12e-05	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—NFKBIA—hematologic cancer	8.57e-06	4.12e-05	CbGpPWpGaD
L-Arginine—NOS3—Disease—CDKN1B—hematologic cancer	8.53e-06	4.1e-05	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—NOTCH1—hematologic cancer	8.49e-06	4.08e-05	CbGpPWpGaD
L-Arginine—NOS2—Disease—MYC—hematologic cancer	8.4e-06	4.04e-05	CbGpPWpGaD
L-Arginine—NOS2—Disease—TGFB1—hematologic cancer	8.38e-06	4.03e-05	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—CD80—hematologic cancer	8.32e-06	4e-05	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—PIK3CG—hematologic cancer	8.3e-06	3.99e-05	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—KIT—hematologic cancer	8.3e-06	3.99e-05	CbGpPWpGaD
L-Arginine—NOS3—Metabolism—PIK3R1—hematologic cancer	8.24e-06	3.96e-05	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—PTPN11—hematologic cancer	8.16e-06	3.92e-05	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—CREB1—hematologic cancer	7.9e-06	3.8e-05	CbGpPWpGaD
L-Arginine—NOS3—Disease—CDKN1A—hematologic cancer	7.87e-06	3.78e-05	CbGpPWpGaD
L-Arginine—NOS3—Disease—PTEN—hematologic cancer	7.85e-06	3.77e-05	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—BRAF—hematologic cancer	7.8e-06	3.75e-05	CbGpPWpGaD
L-Arginine—NOS2—Disease—KRAS—hematologic cancer	7.76e-06	3.73e-05	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—CCL2—hematologic cancer	7.73e-06	3.72e-05	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—IL6R—hematologic cancer	7.71e-06	3.7e-05	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—CREBBP—hematologic cancer	7.7e-06	3.7e-05	CbGpPWpGaD
L-Arginine—NOS3—Metabolism—PIK3CB—hematologic cancer	7.61e-06	3.66e-05	CbGpPWpGaD
L-Arginine—NOS3—Disease—EP300—hematologic cancer	7.49e-06	3.6e-05	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—MAP2K1—hematologic cancer	7.35e-06	3.53e-05	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—PIK3CD—hematologic cancer	7.3e-06	3.51e-05	CbGpPWpGaD
L-Arginine—NOS3—Disease—SRC—hematologic cancer	7.28e-06	3.5e-05	CbGpPWpGaD
L-Arginine—NOS2—Disease—PIK3CA—hematologic cancer	7.13e-06	3.43e-05	CbGpPWpGaD
L-Arginine—NOS3—Disease—STAT3—hematologic cancer	7.02e-06	3.37e-05	CbGpPWpGaD
L-Arginine—NOS3—Disease—NRAS—hematologic cancer	7e-06	3.36e-05	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—FGF2—hematologic cancer	6.99e-06	3.36e-05	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—PIK3R1—hematologic cancer	6.89e-06	3.31e-05	CbGpPWpGaD
L-Arginine—NOS3—Disease—MAPK3—hematologic cancer	6.71e-06	3.22e-05	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—JAK2—hematologic cancer	6.7e-06	3.22e-05	CbGpPWpGaD
L-Arginine—NOS2—Disease—HRAS—hematologic cancer	6.6e-06	3.17e-05	CbGpPWpGaD
L-Arginine—NOS3—Metabolism—PTEN—hematologic cancer	6.57e-06	3.16e-05	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—MDM2—hematologic cancer	6.54e-06	3.14e-05	CbGpPWpGaD
L-Arginine—NOS3—Disease—MYC—hematologic cancer	6.52e-06	3.13e-05	CbGpPWpGaD
L-Arginine—NOS3—Disease—TGFB1—hematologic cancer	6.51e-06	3.13e-05	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—PIK3CB—hematologic cancer	6.36e-06	3.06e-05	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—MTOR—hematologic cancer	6.36e-06	3.06e-05	CbGpPWpGaD
L-Arginine—NOS2—Disease—IL6—hematologic cancer	6.32e-06	3.03e-05	CbGpPWpGaD
L-Arginine—NOS3—Metabolism—EP300—hematologic cancer	6.27e-06	3.01e-05	CbGpPWpGaD
L-Arginine—NOS3—Disease—KRAS—hematologic cancer	6.03e-06	2.9e-05	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—CDKN1B—hematologic cancer	5.97e-06	2.87e-05	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—CASP3—hematologic cancer	5.85e-06	2.81e-05	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—IL2—hematologic cancer	5.84e-06	2.81e-05	CbGpPWpGaD
L-Arginine—NOS2—Disease—AKT1—hematologic cancer	5.83e-06	2.8e-05	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—CCND1—hematologic cancer	5.7e-06	2.74e-05	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—JUN—hematologic cancer	5.68e-06	2.73e-05	CbGpPWpGaD
L-Arginine—NOS3—Disease—PIK3CA—hematologic cancer	5.54e-06	2.66e-05	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—CDKN1A—hematologic cancer	5.51e-06	2.65e-05	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—PTEN—hematologic cancer	5.5e-06	2.64e-05	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—MAPK8—hematologic cancer	5.38e-06	2.58e-05	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—EP300—hematologic cancer	5.24e-06	2.52e-05	CbGpPWpGaD
L-Arginine—NOS3—Disease—HRAS—hematologic cancer	5.12e-06	2.46e-05	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—SRC—hematologic cancer	5.1e-06	2.45e-05	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—VEGFA—hematologic cancer	4.97e-06	2.39e-05	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—STAT3—hematologic cancer	4.92e-06	2.36e-05	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—NRAS—hematologic cancer	4.9e-06	2.36e-05	CbGpPWpGaD
L-Arginine—NOS3—Disease—IL6—hematologic cancer	4.9e-06	2.36e-05	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—MAPK3—hematologic cancer	4.7e-06	2.26e-05	CbGpPWpGaD
L-Arginine—NOS3—Metabolism—PIK3CA—hematologic cancer	4.64e-06	2.23e-05	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—MYC—hematologic cancer	4.57e-06	2.19e-05	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—TGFB1—hematologic cancer	4.56e-06	2.19e-05	CbGpPWpGaD
L-Arginine—NOS3—Disease—AKT1—hematologic cancer	4.52e-06	2.17e-05	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—KRAS—hematologic cancer	4.22e-06	2.03e-05	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—PIK3CA—hematologic cancer	3.88e-06	1.86e-05	CbGpPWpGaD
L-Arginine—NOS3—Metabolism—AKT1—hematologic cancer	3.79e-06	1.82e-05	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—TP53—hematologic cancer	3.75e-06	1.8e-05	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—HRAS—hematologic cancer	3.59e-06	1.72e-05	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—IL6—hematologic cancer	3.43e-06	1.65e-05	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—AKT1—hematologic cancer	3.17e-06	1.52e-05	CbGpPWpGaD
